A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines

Teresa Puig(Institut d'Investigació Biomèdica de Girona), Rámón Colomer(MD Anderson Cancer Center Madrid)
Breast Cancer Research
December 16, 2011
Cited by 94


Related Papers